Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Aspirin (niedrig dosiert) – Forschungsarchiv – Seite 24 von 60 | SupStack

Aspirin (niedrig dosiert) – Forschungsarchiv

Studien 2101–2150 von 3915, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

2101Meta-Analyse2007

Hennekens C · Am J Cardiovasc Drugs (2007)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

Aspirin (niedrig dosiert) – Forschungsarchiv

[Pravastatin and acetylsalycilic acid fixed-combination: a strategy to improve cardiovascular outcomes].

Does clopidogrel rather than aspirin plus a proton-pump inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery?

[Unstable angina: efficacy and tolerability of therapy with aspirin and aspirin combined with ticlopidine].

WITHDRAWN: Antiplatelet agents for preventing and treating pre-eclampsia.

Antiplatelet therapy and the risk of bleeding induced by gastrointestinal endoscopic procedures. A systematic review of the literature and recommendations.

Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial.

Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.

Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.

Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.

A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial.

Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.

Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.

Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.

Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin?

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Clinical observation on 30 cases of transient cerebral ischemia attack treated with acupuncture and medication.

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.

Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis.

Effects of selective cyclooxygenase isoform inhibition on systemic prostacyclin synthesis and on platelet function at rest and after exercise in healthy volunteers.

Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors.

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.

Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting.

Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID.

Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase.

Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.

The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's oesophagus.

Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial.

Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study.

Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers.

Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2.

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.

Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study.

A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease.

Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.

An evaluation of the efficacy of aspirin and benzydamine hydrochloride gargle for attenuating postoperative sore throat: a prospective, randomized, single-blind study.

[Pre-menstrual cyclic mastalgia].

[Prevention of major ischemic events in lower limb arterial disease: does aspirin play a role?].

Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.

Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting.

A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.

A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.

Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, and acetylsalicylic acid.

Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications.

Aspirin in peripheral arterial disease: breakthrough or pitfall?

Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban--an oral, direct factor Xa inhibitor--are not affected by aspirin.

VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty.

Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial.

Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?